PanTher Therapeutics is on a mission to revolutionize cancer care with a proprietary treatment platform designed to enhance therapeutic response with minimal side effects. Our highly adaptable platform empowers oncologists to treat patients with life-threatening cancer by unlocking a drug’s full potential through direct, sustained treatment at the tumor site. This distinctive targeting capability uniquely positions us to take on the deadliest and most difficult to treat cancers with a lead investigational candidate in pancreatic cancer.
Location: United States, Massachusetts, Cambridge
Employees: 1-10
Total raised: $14.2M
Founded date: 2014
Investors 6
| Date | Name | Website |
| - | SideCar An... | sidecarang... |
| - | Walnut Ven... | walnutvent... |
| - | Mission Bi... | missionbio... |
| - | Angel Phys... | angelphysi... |
| - | Catalyst H... | chv.vc |
| - | MIT Alumni... | mitalumnia... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.08.2022 | Grant | $14.2M | - |
Mentions in press and media 1
| Date | Title | Description |
| 18.06.2021 | PanTHer Therapeutics Closes $5.4M in Series A Funding | PanTher Therapeutics, a Cambridge MA-based company advancing treatments for solid tumors, raised $5.4M in Series A funding. The round was led by Catalyst Health Ventures (CHV), with participation from Angel Physicians Fund (APF) and other n... |